The Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance
J.A. Del Campo(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Manuel Romero‐Gómez(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas)
Cited by 24
Related Papers
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
|Journal of Hepatology|2023|183